CMHDF (China Resources Medical Holdings Co) Short-Term Debt: $94 Mil (As of Dec. 2025)


CMHDF China Resources Medical Holdings Co Ltd CMHDF
88 GF Score
Price $0.58
GF Value $0.94
! 5 Warning Signs
View Full Analysis

What is China Resources Medical Holdings Co Short-Term Debt?

China Resources Medical Holdings Co CMHDF 88 Short-Term Debt is $94 Mil as of Dec. 2025. GuruFocus rates CMHDF with a GF Score™ of 88/100 and a GF Value™ of $0.94. The stock has 5 warning signs investors should review.

China Resources Medical Holdings Co's Short-Term Debt for the quarter that ended in Dec. 2025 was $94 Mil.

China Resources Medical Holdings Co's quarterly Short-Term Debt increased from Dec. 2024 ($96 Mil) to Jun. 2025 ($118 Mil) but then declined from Jun. 2025 ($118 Mil) to Dec. 2025 ($94 Mil).

China Resources Medical Holdings Co's annual Short-Term Debt declined from Dec. 2023 ($179 Mil) to Dec. 2024 ($96 Mil) and declined from Dec. 2024 ($96 Mil) to Dec. 2025 ($94 Mil).

China Resources Medical Holdings Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

China Resources Medical Holdings Co Short-Term Debt Related Terms

China Resources Medical Holdings Co Short-Term Debt Historical Data

* Premium members only.

The historical data trend for China Resources Medical Holdings Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Resources Medical Holdings Co Short-Term Debt Chart

China Resources Medical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 261.55 187.99 178.97 96.38 93.82

China Resources Medical Holdings Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 178.97 54.98 96.38 118.40 93.82
CMHDF
88GF Score
China Resources Medical Holdings Co Ltd CMHDF
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $94 Mil mean?
China Resources Medical Holdings Co (CMHDF) has a Short-Term Debt of $94 Mil as of Dec. 2025.
Is China Resources Medical Holdings Co's Short-Term Debt too high?
China Resources Medical Holdings Co's current Short-Term Debt is $94 Mil. Overall, China Resources Medical Holdings Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's Short-Term Debt compare to HCA and THC?
China Resources Medical Holdings Co's Short-Term Debt of $94 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Healthcare Providers & Services company?
A good Short-Term Debt depends on the Healthcare Providers & Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. China Resources Medical Holdings Co's current Short-Term Debt is $94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
China Resources Medical Holdings Co (CMHDF) has a current Short-Term Debt of $94 Mil. The stock's GF Value™ is $0.94, compared to a current price of $0.58 — trading 38.3% below its estimated fair value. The current Short-Term Debt is $94 Mil. China Resources Medical Holdings Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For China Resources Medical Holdings Co (CMHDF), the current Short-Term Debt is $94 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Resources Medical Holdings Co (CMHDF) Overvalued in 2026?

Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued. The current stock price of $0.58 is trading 38.3% below its estimated GF Value™ of $0.94.

Key valuation signals for CMHDF:

  • Short-Term Debt: $94 Mil
  • GF Value™: $0.94 vs. price of $0.58 (38.3% below fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the CMHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Resources Medical Holdings Co Business Description

Other Exchanges 01515:Hong Kong1PH:Germany
Address No. 9, Fuyi Street, 14th Floor, Kunlun Center Office Building, Fengtai District, Beijing, CHN, 100069
China Resources Medical Holdings Co Ltd is engaged in the provision of general healthcare services; provision of hospital management services, sale of pharmaceuticals, medical devices, and medical consumables, and provision of other services in the Chinese Mainland. The group has two operating segments: Hospital Business and Other Business. The Hospital Business segment includes outpatient business and inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services, and other ancillary services provided to participating hospitals and IOT/OT hospitals. It generates the majority of its revenue from the Hospital Business segment.
88GF Score

Get the complete analysis for CMHDF

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.58
Price
$0.94
GF Value